We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Point-Of-Care Tool Diagnoses Genetic Mutations within Hours

By LabMedica International staff writers
Posted on 07 Feb 2024
Print article
Image: The point-of-care kit is designed to diagnose genetic mutations (Photo courtesy of University of Calgary)
Image: The point-of-care kit is designed to diagnose genetic mutations (Photo courtesy of University of Calgary)

Blood disorders like sickle cell anemia arise from genetic mutations. Typically, newborns are screened for sickle cell disease at birth, with any irregularities reported within 96 hours. However, a follow-up blood test is necessary to confirm the diagnosis, and obtaining these results can take between two to four weeks. Often, seeking genetic analysis through specialized private laboratories can be both time-consuming and expensive. Now, a new tool can detect the presence of genetic mutations within hours instead of weeks.

Researchers at the University of Calgary (Alberta, Canada) have created a system named One-pot DTECT. This innovation is designed for simplicity and ease of use, enabling any laboratory in the world to quickly set up its own kit for same-day genetic mutation analysis at a minimal cost per sample. One-pot DTECT comprises multiple enzymes and distinct DNA fragments that work together to identify and detect genetic signatures. The compact kit includes a small metal box containing 16 vials filled with DNA fragments and an additional two vials of enzymes. This versatile kit is capable of diagnosing a broad spectrum of genetic mutations associated with various disorders, including sickle cell anemia and cystic fibrosis.

Beyond diagnosing patients, the kit is useful for routine laboratory experiments and identifying genetic mutations. The test’s accuracy has been validated, enabling direct analysis from the original blood spot with results available within hours. Discussions are underway with several companies for commercial distribution of the kits. However, the technology is simple and cost-effective, allowing laboratories to easily produce their own kits. The process simply requires specific DNA fragments for sequencing and the necessary enzymes, which are readily available from suppliers.

Related Links:
University of Calgary

New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)
New
Washer Disinfector
Tiva 8
New
Hematology Analyzer
XS-500i

Print article

Channels

Hematology

view channel
Image: The study examined the diagnostic utility of ELISA testing for heparin-induced thrombocytopenia (Photo courtesy of 123RF)

Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy

Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read more

Microbiology

view channel
Image: Genetic testing can determine which drugs will work for patients with C. auris (Photo courtesy of Shutterstock)

Genetic Testing Could Improve Treatment for Virulent Multidrug-Resistant Fungus Candida Auris

Candida auris (C. auris), a multidrug-resistant yeast responsible for severe, life-threatening infections, was first identified in 2009. Since its discovery, it has spread globally, causing significant... Read more

Pathology

view channel
Image: The Roche Cell Collection Medium provides long-term stability for cervical specimens collected via self-collection (Photo courtesy of Roche)

New Self-Collection Medical Test Makes HPV Screening Easier for Patients

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection (STI) in the U.S. HPV spreads through skin-to-skin contact, typically during sexual activity with someone who carries the virus.... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.